With COVID-19 cases on the rise again in the U.S., Americans are reviving a familiar precautionary measure: Screening for the virus using rapid at-home tests. Many people still have kits the ...

The KP.3 COVID-19 variant is continuing to lead as the dominant variant, the newest Centers for Disease Control and Prevention (CDC) data shows. For a two-week period starting on June 23 and ending on ...

More than half of states are now seeing "high" or "very high" levels of SARS-CoV-2, the virus that causes COVID-19, in their wastewater testing, according to figures published Friday by the Centers ...

Dat ook baby’s en jonge kinderen het slachtoffer worden van het coronavirus, leidt tot veel bezorgdheid bij heel wat ouders, zeker als hun kinderen symptomen vertonen. De artsen en ziekenhuizen ...

If the COVID-19 pandemic has done one thing, it’s made us all more familiar with some of the important players in the immune system. Antibodies, B cells, and T cells are among the best known parts of ...

Coronavirus transmission has been slowly, but steadily, on the rise in recent weeks — and though local public health officials say the most recently available data doesn’t yet indicate a surge akin to ...

Pew Research Center conducted this study to understand Americans’ views of the coronavirus and COVID-19 vaccines. For this analysis, we surveyed 10,133 U.S. adults from Feb. 7 to 11, 2024. Everyone ...

The latest COVID-19 boosters were approved last month, but not everyone has been able to get them yet. The updated vaccine doses, which the Food and Drug Administration approved in late August, are ...

People who contracted COVID-19 will be at a heightened risk for developing health problems, according to the results of a new study published Monday. The study, published in Nature Medicine, analyzed ...

It’s late August, there’s a hurricane coming up the East Coast, schools are starting to open, and no one has any idea who can get an updated Covid-19 shot. The Covid-19 pandemic is over, but the virus ...

We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...